Search research articles
Contact Us
Filters
Showing results (251-260 of 315) with videos related to
Page
of 32
Sort By:
Breast Cancer Research : BCR
|
April 8, 2015
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy
Jieping Lei, Anja Rudolph, Kirsten B Moysich, et al.
Scientific Reports
|
December 2, 2015
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1
Timothy H T Cheng, Deborah Thompson, Jodie Painter, et al.
Oncotarget
|
December 3, 2016
Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration
Jennifer B Permuth, Brett Reid, Madalene Earp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2015
Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium
Sharon E Johnatty, Jonathan P Tyrer, Siddhartha Kar, et al.
The Journal of Pathology. Clinical Research
|
August 1, 2018
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study
Peter F Rambau, Robert A Vierkant, Maria P Intermaggio, et al.
JAMA Oncology
|
October 20, 2017
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
, Ellen L Goode, Matthew S Block, et al.
Cancer Research
|
December 19, 2018
Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk
Yaohua Yang, Lang Wu, Xiang Shu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Nature
|
May 29, 2007
Genome-wide association study identifies novel breast cancer susceptibility loci
Douglas F Easton, Karen A Pooley, Alison M Dunning, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 21, 2023
Concurrent RB1 loss and <i>BRCA</i>-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Page
of 32
Search research articles
Search
Showing results (251-260 of 315) with videos related to
Sort By:
Page
of 32
Breast Cancer Research : BCR
|
April 8, 2015
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy
Jieping Lei, Anja Rudolph, Kirsten B Moysich, et al.
Scientific Reports
|
December 2, 2015
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1
Timothy H T Cheng, Deborah Thompson, Jodie Painter, et al.
Oncotarget
|
December 3, 2016
Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration
Jennifer B Permuth, Brett Reid, Madalene Earp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2015
Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium
Sharon E Johnatty, Jonathan P Tyrer, Siddhartha Kar, et al.
The Journal of Pathology. Clinical Research
|
August 1, 2018
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study
Peter F Rambau, Robert A Vierkant, Maria P Intermaggio, et al.
JAMA Oncology
|
October 20, 2017
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
, Ellen L Goode, Matthew S Block, et al.
Cancer Research
|
December 19, 2018
Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk
Yaohua Yang, Lang Wu, Xiang Shu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Nature
|
May 29, 2007
Genome-wide association study identifies novel breast cancer susceptibility loci
Douglas F Easton, Karen A Pooley, Alison M Dunning, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 21, 2023
Concurrent RB1 loss and <i>BRCA</i>-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Page
of 32